Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2'-modified nucleosides. In particular, disubstitution at the C-2' position of nucleosides has resulted in significant activity against the hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2'-modified tricyclic nucleosides. Details of the synthesis, structural characterization, and preliminary biological results are reported.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975515 | PMC |
| http://dx.doi.org/10.1021/ol101482h | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Late-Stage Functionalization of Guanine-Based Nucleosides, Nucleotides, and Oligonucleotide: Synthesis and Derivatization of Tricyclic Nucleoside Analogues.
Org Lett
December 2024
School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, China.
We report here the synthesis of tricyclic nucleoside analogues via acid-catalyzed cyclization of guanine with 1,1,3,3-tetramethoxypropane. The method enables the use of hydroxyl-unprotected antiviral drugs (acyclovir, ganciclovir, and penciclovir), guanosines, oligonucleotide, and triazole-linked nucleoside dimers as substrates. Nucleoside trimer and tetramer were synthesized by derivatization reactions.
View Article and Find Full Text PDFThe ex vivo effects of hypoxanthine-tricyclano, a synthetic adenosine analogue, on rat left and right atria.
Gen Physiol Biophys
November 2024
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Hypoxanthine-tricyclano is a synthetic adenosine analogue, in which adenine and ribose have been replaced by hypoxanthine and a morpholino-derived tricyclic moiety, respectively. We investigated whether hypoxanthine-tricyclano could influence atrial inotropy and/or chronotropy, two important functions regulated by the A1 receptor, the main adenosine receptor type of the supraventricular myocardium. Paced left atria and spontaneously beating right atria, isolated from male, 30-35 weeks old, Wistar rats, were used.
View Article and Find Full Text PDFInteraction of Tri-Cyclic Nucleobase Analogs with Enzymes of Purine Metabolism: Xanthine Oxidase and Purine Nucleoside Phosphorylase.
Int J Mol Sci
September 2024
Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, ul. Pasteura 5, PL-02-093 Warsaw, Poland.
Fluorescent markers play important roles in spectroscopic and microscopic research techniques and are broadly used in basic and applied sciences. We have obtained markers with fluorescent properties, two etheno derivatives of 2-aminopurine, as follows: 1,N-etheno-2-aminopurine (1,N-ε2APu, ) and N,3-etheno-2-aminopurine (N,3-ε2APu, ). In the present paper, we investigate their interaction with two key enzymes of purine metabolism, purine nucleoside phosphorylase (PNP), and xanthine oxidase (XO), using diffraction of X-rays on protein crystals, isothermal titration calorimetry, and fluorescence spectroscopy.
View Article and Find Full Text PDFSignaling effect, combinations, and clinical applications of triciribine.
J Chemother
September 2024
Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Article Synopsis
- - Triciribine (TCN), a tricyclic nucleoside first synthesized in 1971, inhibits DNA synthesis and is particularly selective for the Akt pathway.
- - Although TCN showed limited single-agent effectiveness in solid tumors, it has demonstrated promising results when combined with various other treatments like dasatinib and gemcitabine against cancers like pancreatic and breast.
- - Beyond cancer treatment, TCN’s ability to inhibit Akt suggests potential benefits for treating lung injuries, including those caused by COVID-19.
Skeletal Transformations Observed in the Reaction of a Tricyclic Thymine Nucleoside with Dicarbonyl Compounds.
ACS Omega
August 2024
Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Some intriguing skeletal transformations were observed in the reaction of α-hydroxypyrrolidine thymine nucleoside with different dicarbonyl compounds. In these reactions, unusual ring systems, together with new C-C bonds and stereogenic centers of defined configuration, were formed in a single step. These reactions were initiated by the nucleophilic attack of the NH of the pyrrolidine ring, present on , on one of the carbonyl moieties of a dicarbonyl reagent and seem to proceed through an enamine-iminium mechanism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!